Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BYFrontiers in pediatrics

Case Report: Smith-Magenis syndrome with bilateral high-grade vesicoureteral reflux, hypothyroidism, and seizure in infancy

  1. 1Department of Pediatric Nephrology, Rheumatology and Immunology, Children’s Hospital of Jiangnan University (Wuxi Children’s Hospital) , , ,

Abstract

Smith-Magenis syndrome (SMS) is a rare neurodevelopmental and multisystem disorder caused mainly by 17p11.2 deletions involving RAI1. Because the characteristic behavioral and sleep phenotype may not yet be apparent, diagnosis in infancy can be challenging. We report a 9-month-old boy with recurrent febrile urinary tract infection, bilateral hydronephrosis with ureteral dilatation, hypothyroidism, global developmental delay, hypotonia, brachydactyly, dysmorphic features, phimosis, and short penis. Voiding cystourethrography demonstrated bilateral grade IV vesicoureteral reflux (VUR). Renal scintigraphy showed focal right renal cortical defects; DTPA effective renal plasma flow was 180.33 mL/min in the left kidney and 133.77 mL/min in the right kidney, corresponding to split function of 57.4% and 42.6%. Trio whole-exome sequencing with copy-number-variant analysis identified a de novo 3.63-Mb deletion at 17p11.2 encompassing RAI1, confirming SMS; a maternally inherited heterozygous DUOX2 likely pathogenic variant was also detected, but its contribution to hypothyroidism remains unproven. Infection improved with antibiotics, levothyroxine was resumed, and amoxicillin/clavulanate prophylaxis was initiated. Surgery for phimosis was postponed after an afebrile sleep-related seizure. Follow-up showed improved renal indices, no recurrent urinary tract infection, normalized thyroid function, and no definite abnormality on video-electroencephalography, although developmental delay persisted and brief seizure-like ocular events remained under evaluation. This case shows that high-grade bilateral VUR with recurrent infection and a syndromic neurodevelopmental phenotype can be an early presentation of SMS and warrants copy-number analysis, renal protection, and coordinated endocrine, neurologic, developmental, and urologic follow-up.

Related

  1. Hyperexcitable but seizure-free: hippocampal network dysfunction in a Wolfram syndrome model
    S. Ahmadi, J. G. Pinera, S. Dokholyan +15
    bioRxivPreprintCC BYFull textNeurosciencebioRxiv
  2. Serum reverse triiodothyronine in dogs with hypothyroidism, nonthyroidal illness syndrome and healthy dogs
    Julia Ruß, Ralf S. Mueller, Katharina Glos +5
    PLOS OnePeer-reviewedCC BY 4.0Full textZoology & animal behaviourEndocrinology & metabolismPLOS
  3. P2X7 receptor antagonism potentiates seizure-suppressive effects of anti-seizure medications in human resected epileptic brain tissue
    A. Fernandez Martin, B. Gil, M. Mitra +18
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  4. CLSP-REQA: a real-time quality-aware closed-loop seizure prediction framework with Mamba-BiLSTM and confidence-gated intervention
    Mufeng Chen, Qi Wu, Bingchao Huang +4
    Frontiers in neuroinformaticsPeer-reviewedCC BYFull textNeuroscienceEurope PMC
  5. Postnatal exposure to maternal hypothyroidism leads to developmental delay and metabolic dysregulations in male mice
    Anouk Fontaine, Noémie Sallen, Karine Gauthier
    EndocrinologyPeer-reviewedCC BY 4.0Full textDevelopmental biologyEndocrinology & metabolismHAL
BibTeX
@article{cheng2026case,
  title = {{Case Report: Smith-Magenis syndrome with bilateral high-grade vesicoureteral reflux, hypothyroidism, and seizure in infancy}},
  author = {Yun Cheng and Xunwei Liu and Lingyun Yang and Jinwen Xu},
  journal = {Frontiers in pediatrics},
  year = {2026},
  month = oct,
  doi = {10.3389/fped.2026.1906694},
  url = {https://europepmc.org/article/PMC/PMC13716811},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Case Report: Smith-Magenis syndrome with bilateral high-grade vesicoureteral reflux, hypothyroidism, and seizure in infancy
AU  - Yun Cheng
AU  - Xunwei Liu
AU  - Lingyun Yang
AU  - Jinwen Xu
PY  - 2026
DA  - 2026/10/15
JO  - Frontiers in pediatrics
DO  - 10.3389/fped.2026.1906694
UR  - https://europepmc.org/article/PMC/PMC13716811
AB  - Smith-Magenis syndrome (SMS) is a rare neurodevelopmental and multisystem disorder caused mainly by 17p11.2 deletions involving RAI1. Because the characteristic behavioral and sleep phenotype may not yet be apparent, diagnosis in infancy can be challenging. We report a 9-month-old boy with recurrent febrile urinary tract infection, bilateral hydronephrosis with ureteral dilatation, hypothyroidism, global developmental delay, hypotonia, brachydactyly, dysmorphic features, phimosis, and short penis. Voiding cystourethrography demonstrated bilateral grade IV vesicoureteral reflux (VUR). Renal scintigraphy showed focal right renal cortical defects; DTPA effective renal plasma flow was 180.33 mL/min in the left kidney and 133.77 mL/min in the right kidney, corresponding to split function of 57.4% and 42.6%. Trio whole-exome sequencing with copy-number-variant analysis identified a de novo 3.63-Mb deletion at 17p11.2 encompassing RAI1, confirming SMS; a maternally inherited heterozygous DUOX2 likely pathogenic variant was also detected, but its contribution to hypothyroidism remains unproven. Infection improved with antibiotics, levothyroxine was resumed, and amoxicillin/clavulanate prophylaxis was initiated. Surgery for phimosis was postponed after an afebrile sleep-related seizure. Follow-up showed improved renal indices, no recurrent urinary tract infection, normalized thyroid function, and no definite abnormality on video-electroencephalography, although developmental delay persisted and brief seizure-like ocular events remained under evaluation. This case shows that high-grade bilateral VUR with recurrent infection and a syndromic neurodevelopmental phenotype can be an early presentation of SMS and warrants copy-number analysis, renal protection, and coordinated endocrine, neurologic, developmental, and urologic follow-up.
SN  - 2296-2360
ER  -